SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Piero Perucca, Marco Mula, Antiepileptic drug effects on mood and behavior: Molecular targets, Epilepsy & Behavior, 2013, 26, 3, 440

    CrossRef

  2. 2
    Stefano Comai, Michael Tau, Zoran Pavlovic, Gabriella Gobbi, The Psychopharmacology of Aggressive Behavior, Journal of Clinical Psychopharmacology, 2012, 32, 2, 237

    CrossRef

  3. 3
    Daniel J. Safer, Age-Grouped Differences in Adverse Drug Events from Psychotropic Medication, Journal of Child and Adolescent Psychopharmacology, 2011, 21, 4, 299

    CrossRef

  4. 4
    Dewi Frances T. Depositario-Cabacar, Tesfaye-Getaneh Zelleke, Treatment of epilepsy in children with developmental disabilities, Developmental Disabilities Research Reviews, 2010, 16, 3
  5. 5
    Gregory L. Holmes, Qian Zhao, Choosing the Correct Antiepileptic Drugs: From Animal Studies to the Clinic, Pediatric Neurology, 2008, 38, 3, 151

    CrossRef

  6. 6
    Hee Hwang, Ki Joong Kim, New antiepileptic drugs in pediatric epilepsy, Brain and Development, 2008, 30, 9, 549

    CrossRef

  7. 7
    Ian Gilron, Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions, Current Opinion in Anaesthesiology, 2007, 20, 5, 456

    CrossRef

  8. 8
    Udo Bonnet, Michael Specka, F. Markus Leweke, Peter Nyhuis, Markus Banger, Gabapentin's acute effect on mood profile — A controlled study on patients with alcohol withdrawal, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, 31, 2, 434

    CrossRef

  9. 9
    Marco Mula, Josemir W Sander, Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy, Drug Safety, 2007, 30, 7, 555

    CrossRef

  10. 10
    David W. Loring, Susan Marino, Kimford J. Meador, Neuropsychological and Behavioral Effects of Antiepilepsy Drugs, Neuropsychology Review, 2007, 17, 4, 413

    CrossRef

  11. 11
    David R. P. Guay, Newer Antiepileptic Drugs in the Management of Agitation/Aggression in Patients with Dementia or Developmental Disability, The Consultant Pharmacist, 2007, 22, 12, 1004

    CrossRef

  12. 12
    Bettina Schmitz, Effects of Antiepileptic Drugs on Mood and Behavior, Epilepsia, 2006, 47,
  13. 13
    Thomas Bookwalter, Matthew Gitlin, Gabapentin-Induced Neurologic Toxicities, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005, 25, 12
  14. 14
    Frank MC Besag, Behavioural effects of the newer antiepileptic drugs: an update, Expert Opinion on Drug Safety, 2004, 3, 1, 1

    CrossRef

  15. 15
    Elizabeth B Weller, Arman K Danielyan, Ronald A Weller, Somatic treatment of bipolar disorder in children and adolescents, Psychiatric Clinics of North America, 2004, 27, 1, 155

    CrossRef

  16. 16
    Blaise Bourgeois, Epilepsy in Children, 2E, 2004,

    CrossRef

  17. 17
    E. Hirsch, B. Schmitz, M. Carreño, Epilepsy, antiepileptic drugs (AEDs) and cognition, Acta Neurologica Scandinavica, 2003, 108,
  18. 18
    Ann M Bergin, Pharmacotherapy of paediatric epilepsy, Expert Opinion on Pharmacotherapy, 2003, 4, 4, 421

    CrossRef

  19. 19
    Randa G. Jarrar, Jeffrey R. Buchhalter, Therapeutics in Pediatric Epilepsy, Part 1: The New Antiepileptic Drugs and the Ketogenic Diet, Mayo Clinic Proceedings, 2003, 78, 3, 359

    CrossRef

  20. 20
    Andres M Kanner, Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment, Epilepsy & Behavior, 2002, 3, 6, 7

    CrossRef

  21. 21
    Kenneth R Alper, John J Barry, Antoaneta J Balabanov, Treatment of psychosis, aggression, and irritability in patients with epilepsy, Epilepsy & Behavior, 2002, 3, 5, 13

    CrossRef

  22. 22
    ANNE AUSTIN WEISSENBERGER, MARY LYNN DELL, KORE LIOW, WILLIAM THEODORE, CAROL M. FRATTALI, DAPHNE HERNANDEZ, ALAN J. ZAMETKIN, Aggression and Psychiatric Comorbidity in Children With Hypothalamic Hamartomas and Their Unaffected Siblings, Journal of the American Academy of Child & Adolescent Psychiatry, 2001, 40, 6, 696

    CrossRef

  23. 23
    Frank M.C. Besag, Behavioural Effects of the New Anticonvulsants, Drug Safety, 2001, 24, 7, 513

    CrossRef

  24. 24
    Csaba Juhász, Michael E. Behen, Otto Muzik, Diane C. Chugani, Harry T. Chugani, Bilateral Medial Prefrontal and Temporal Neocortical Hypometabolism in Children with Epilepsy and Aggression, Epilepsia, 2001, 42, 8
  25. 25
    Patrick Kwan, Martin J Brodie, Neuropsychological effects of epilepsy and antiepileptic drugs, The Lancet, 2001, 357, 9251, 216

    CrossRef

  26. 26
    Sheila J. Wallace, Newer antiepileptic drugs: advantages and disadvantages, Brain and Development, 2001, 23, 5, 277

    CrossRef

  27. 27
    Ian C.K. Wong, Samden D. Lhatoo, Adverse Reactions to New Anticonvulsant Drugs, Drug Safety, 2000, 23, 1, 35

    CrossRef

  28. 28
    Benjamin Bar-Oz, Irena Nulman, Gideon Koren, Shinya Ito, Anticonvulsants and Breast Feeding, Pediatric Drugs, 2000, 2, 2, 113

    CrossRef

  29. 29
    Eugen Trinka, Ulrike Niedermüller, Claudia Thaler, Stephan Doering, Titus Moroder, Gunther Ladurner, Gerhard Bauer, Gabapentin-induced mood changes with hypomanic features in adults, Seizure, 2000, 9, 7, 505

    CrossRef

  30. 30
    Blaise F.D Bourgeois, New Antiepileptic Drugs in Children: Which Ones for Which Seizures?, Clinical Neuropharmacology, 2000, 23, 3, 119

    CrossRef

  31. 31
    Solomon L. Moshé, Special Considerations in Treating Children with Epilepsy, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000, 20, 8P2
  32. 32
    Brenda C. McClain, Sean Ennevor, The use of gabapentin in pediatric patients with neuropathic pain, Seminars in Anesthesia, Perioperative Medicine and Pain, 2000, 19, 2, 83

    CrossRef

  33. 33
    Cynthia L. Harden, Therapeutic Safety Monitoring: What to Look for and When to Look for It, Epilepsia, 2000, 41,
  34. 34
    John M. Pellock, Lawrence D. Morton, Treatment of epilepsy in the multiply handicapped, Mental Retardation and Developmental Disabilities Research Reviews, 2000, 6, 4
  35. 35
    John M. Pellock, Treatment of Epilepsy in the New Millennium, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000, 20, 8P2
  36. 36
    Laura Sanchez, Owen Hagino, Elizabeth Weller, Ronald Weller, BIPOLARITY IN CHILDREN, Psychiatric Clinics of North America, 1999, 22, 3, 629

    CrossRef

  37. 37
    Carl B Dodrill, John L Arnett, Aileen G Hayes, Elizabeth A Garofalo, Christina A Greeley, Martha J Greiner, Mark W Pierce, Cognitive abilities and adjustment with gabapentin: results of a multisite study, Epilepsy Research, 1999, 35, 2, 109

    CrossRef

  38. 38
    K. J. Meador, D. W. Loring, P. G. Ray, A. M. Murro, D. W. King, M. E. Nichols, E. M. Deer, W. T. Goff, Differential Cognitive Effects of Carbamazepine and Gabapentin, Epilepsia, 1999, 40, 9
  39. 39
    George L. Morris, Gabapentin, Epilepsia, 1999, 40,
  40. 40
    Elisabeth Korn-Merker, Peter Borusiak, Hans Erich Boenigk, Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety, Epilepsy Research, 1999, 38, 1, 27

    CrossRef

  41. 41
    Michael J. McLean, Gabapentin in the Management of Convulsive Disorders, Epilepsia, 1999, 40,
  42. 42
    Laura Letterman, John S. Markowitz, Gabapentin: A Review of Published Experience in the Treatment of Bipolar Disorder and Other Psychiatric Conditions, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999, 19, 5
  43. 43
    Bettina Schmitz, Psychiatric Syndromes Related to Antiepileptic Drugs, Epilepsia, 1999, 40,
  44. 44
    John M. Pellock, Richard Appleton, Use of New Antiepileptic Drugs in the Treatment of Childhood Epilepsy, Epilepsia, 1999, 40,
  45. 45
    Blaise F. D. Bourgeois, Antiepileptic Drugs, Learning, and Behavior in Childhood Epilepsy, Epilepsia, 1998, 39, 9
  46. 46
    Jean A. Hannah, Martin J. Brodie, Epilepsy and learning disabilities—a challenge for the next millennium?, Seizure, 1998, 7, 1, 3

    CrossRef

  47. 47
    Elaine A Wilson, Graeme J Sills, Gerard Forrest, Martin J Brodie, High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients, Epilepsy Research, 1998, 29, 2, 161

    CrossRef

  48. 48
    Alan B. Ettinger, Deborah M. Weisbrot, Jennifer Saracco, Aliasgar Dhoon, Andres Kanner, Yorrin Devinsky, Positive and Negative Psychotropic Effects of Lamotrigine in Patients with Epilepsy and Mental Retardation, Epilepsia, 1998, 39, 8
  49. 49
    Jean A Hannah, Martin J Brodie, Treatment of Seizures in Patients with Learning Disabilities, Pharmacology & Therapeutics, 1998, 78, 1, 1

    CrossRef

  50. 50
    Gregory L. Holmes, Gabapentin for treatment of epilepsy in children, Seminars in Pediatric Neurology, 1997, 4, 3, 244

    CrossRef

  51. 51
    John M. Pellock, Nathan Watemberg, New antiepileptic drugs in children: Present and future, Seminars in Pediatric Neurology, 1997, 4, 1, 9

    CrossRef

  52. 52
    Colin D Ferrie, John H Livingston, The new anti-epileptic drugs: A review, European Journal of Paediatric Neurology, 1997, 1, 5-6, 139

    CrossRef

  53. 53
    Emilio Perucca, 1997,

    CrossRef

  54. 54
    &NA;, Gabapentin, Reactions Weekly, 1996, &NA;, 585, 7

    CrossRef

  55. 55
    Richard H. Mattson, The Role of the Old and the New Antiepileptic Drugs in Special Populations: Mental and Multiple Handicaps, Epilepsia, 1996, 37,
  56. 56
    Mary L. Zupanc, Update on Epilepsy in Pediatric Patients, Mayo Clinic Proceedings, 1996, 71, 9, 899

    CrossRef

  57. 57
    Janine Beavis, Michael Kerr, Anthony G Marson, Ivana Dojcinov, Pharmacological interventions for epilepsy in people with intellectual disabilities, The Cochrane Library,
  58. 58
    J Beavis, M Kerr, AG Marson, Pharmacological interventions for epilepsy in people with intellectual disabilities, The Cochrane Library,